DPP4 and Parkinson disease: Genetically proxied DPP-4 inhibition was associated with reduced PD risk: OR (95% CI) ​= ​1.78 (1.21-2.61) for IV<sub>eQTL</sub> and 1.21 (1.02-1.45) for IV<sub>pQTL</sub>.